Kapp Joachim Friedrich - Insider Stock Trading - OpenInsider

CIK: 1338543 - Address: 400 Oyster Point Blvd., Suite 505, So. San Francisco, CA 94080

7 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	1	3	4	0	27	44	6	17
P	%wins				100	100	100	100	100	100	100
S	%ret	1	1	1	-4	4	-7	22	33	16	11
S	%wins				100	0	100	0	0	0	33

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/1/10 18:00	10/13/10	TTNP	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	H	Former D	S.am	-741	1.33	0	-559	-51	546	D	838	-27	-2	17	36	7	-8	2	-4	4	-7	22	33	16
10/27/10 17:07	10/13/10	TTNP	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P.m	741	1.33	0	559		546	D	823	-28	-26	8	30	11	-7	-5	3	4	0	27	44	6
12/12/08 18:51	12/11/08	AMEX.	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P	28	0.0350	0	800	400	1,000	D
8/15/08 15:34	8/13/08	AMEX.	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P.m	47	0.4680	0	100	100	200	D
7/8/08 20:28	7/3/08	AMEX.	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P.m	42	0.8314	0	50	100	100	D
2/13/08 14:21	2/11/08	AMEX.	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P	40	1.33	0	30	150	50	D
11/6/07 13:23	11/2/07	AMEX.	Titan Pharmaceuticals Inc	DE	Health	BioPrd	Biological Products, (No Diag	Kapp Joachim Friedrich	CA	D		P	38	1.91	0	20	New	20	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact